No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.2x · 10Y median 62.3x · 13th percentile · as of Oct 5, 2026
Annualized revenue (TTM) · by quarter, last 25
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T11:15:52.367Z. Latest historical point 2022-06-30. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T11:15:52.367Z. Latest historical point 2025-10-20.
EV/EBITDA and cash-flow multiples are withheld until their applicability to this financial-services business is verified. The lenses that apply are shown above; see also P/B and ROE.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T11:15:52.367Z. Latest historical point 2025-10-20.
EBITDA and cash-flow yields are withheld until their applicability to this financial-services business is verified. Earnings yield is shown above; see also P/B and ROE.
The latest delayed quote for Beneficient (BENF) stock was $1.31 as of Oct 5, 2026, 4:00 PM EDT, down 8.39% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -81.5% · 3-year avg -88.8%/yr
Beneficient operates as a technology-driven financial services provider, specializing in delivering liquidity solutions to entities within the alternative asset market. The company manages the AltAccess platform, a comprehensive digital ecosystem designed to facilitate the entire spectrum of alternative asset management, from transactions to secure custody and detailed analytics.
Asset Management · Dallas, TX
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-0.47
vs Estimate
$-2.51
Revenue
$12.16M
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1BENF | $1.52M | $1.31 | -8.39% | -81.45% | N/A | N/A | N/A |
| 2AURE | $338,569 | $1.07 | +3.88% | -86.50% | N/A | N/A | vs BENF |
| 3ABTS | $3.61M | $1.22 | +3.20% | -87.85% | -59.11% | -44.04% | vs BENF |
| 4AXG | $4.57M | $0.10 | -8.70% | -96.16% | N/A | N/A | vs BENF |
| 5CWD | $4.65M | $0.55 | -3.45% | -87.91% | N/A | N/A | vs BENF |
| 6BCG | $17.65M | $1.05 | +3.96% | -38.09% | N/A | N/A | vs BENF |
N/A
vs Estimate
$13.10M
Consensus Rating
Based on 1 analyst
Average Price Target
$9.00
+587.0% upside
Low
$9.00
Current
$1.31
High
$9.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-1.29 | $-1.29 | $-1.29 | 1 |
| Quarter ending Dec 2026 | $-0.47 | $-0.47 | $-0.47 | 1 |
| Quarter ending Mar 2027 | $0.71 | $0.71 | $0.71 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $-1.67 | $-1.66 | $-1.65 | 1 |
| FY 2028 | $0.01 | $0.01 | $0.01 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $14.53M | $14.53M | $14.53M | 1 |
| Quarter ending Dec 2026 | $16.52M | $16.52M | $16.52M | 1 |
| Quarter ending Mar 2027 | $18.36M | $18.36M | $18.36M | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| FY 2027 |
| $48.71M |
| $50.29M |
| $51.89M |
| 1 |
| FY 2028 | $48.28M | $48.59M | $48.91M | 1 |
